Live Chat

تداول Vir Biotechnology VIR

البيع
 شراء

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date إغلاق change معدل التغيير (%) instr__open مرتفع منخفض

Markets.com news

bitcoin dropping
Antonio Ferlito 2024 Aug 19, 16:05

Test News Article Arabic Only

CFD Trading BoE
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

الأسبوع القادم: نتائج الانتخابات الفرنسية هامة بالنسبة للأسواق الأوروبية

الفوركس المؤشرات
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

الأسبوع القادم: هل تتسبب فرنسا في أزمة جديدة لليورو؟

CPI
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

الأسبوع القادم: البنك الأسترالي، البنك البريطاني.. الثبات أم التغيير؟

الفوركس المؤشرات

معلومات

الفارق الهامشي

0.05

الهامش (%)

0.6623 %

الرافعة المالية

1:10

فائدة الشراء بين ليلة وضحاها

-0.0597 %

فائدة البيع بين ليلة وضحاها

-0.0292 %

عملة

USD

ساعات التداول

السوق مغلق

الثلاثاء

14:31 - 20:59

الاثنين

14:31-20:59

الأربعاء

14:31-20:59

الخميس

14:31-20:59

الجمعة

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1010864832

instr__shares_outstand

137720000

instr__earnings_date

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-3.93

instrument_learn_more

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

related_instruments

الأصل
البيع
شراء
معدل التغيير (%)

تداول الآن

تداول الآن

تداول الآن

تداول الآن
view_all_instruments
Trustpilot
Live Chat